Seema Dawood: Microscopic Findings, Pathophysiology and Associated Conditions of Thrombophagocytosis
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on LinkedIn:
“Thrombophagocytosis
Thrombophagocytosis is a phenomenon in which white blood cells – most commonly Monocytes or Macrophages (histiocytes) – engulf platelets within their cytoplasm.
Microscopic Findings
- Platelets are observed inside the cytoplasm of macrophages or histiocytes
- Commonly associated with thrombocytopenia (low platelet count)
Pathophysiology:
Thrombophagocytosis results from severe immune system activation, leading to excessive macrophage activation.
Activated macrophages abnormally phagocytose blood cells, including platelets.
Associated Conditions
- Hemophagocytic lymphohistiocytosis (HLH) – most common and clinically significant
- Severe infections (e.g., Dengue fever, EBV, CMV, sepsis)
- Autoimmune diseases (e.g., systemic lupus erythematosus; SLE)
- Certain Hematologic malignancies
Represents a marker of severe immune activation
When found together with:
- Thrombocytopenia
- Multilineage cytopenia
- Persistent fever and hepatosplenomegaly
HLH should be strongly suspected, and further evaluation is urgently required.
HLH and Thrombophagocytosis
Hemophagocytic lymphohistiocytosis (HLH) is a disorder characterized by uncontrolled and severe immune activation.
It results from impaired function of NK cells and cytotoxic T lymphocytes, leading to:
- Failure to regulate immune responses
- Persistent activation of macrophages
- In HLH, macrophage activation is excessive and sustained
Activated macrophages perform hemophagocytosis, engulfing various blood cells:
- Platelets – Thrombophagocytosis
- Red blood cells – Erythrophagocytosis
- White blood cells – Leukophagocytosis
Therefore, thrombophagocytosis is one of the characteristic morphologic findings in HLH and supports the diagnosis when correlated with clinical and laboratory features.”
Other posts featuring Seema Dawood on Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery